This document is a published patent application (US20260085298A1) from the USPTO, filed on August 5, 2024, by GUILIN LAYN NATURAL INGREDIENTS CORP. It describes a novel method for synthesizing rebaudioside M2, a component often used in food and pharmaceutical applications, utilizing a specific glycosyltransferase (UGT94D1). The application highlights the efficiency and environmental benefits of this biocatalytic process, noting the absence of by-products which simplifies purification and lowers costs.

While this is a patent application and not a regulatory rule, it signals potential innovation in the production of rebaudioside M2. Companies involved in the production or use of steviol glycosides, particularly rebaudioside M2, should be aware of this patented technology. Compliance officers in the pharmaceutical and food manufacturing sectors may need to monitor the patent's progress and consider its implications for intellectual property and manufacturing processes.